Nkarta to Participate in Upcoming Investor Conferences
Wednesday, April 3, 2024 1 min read
Key Takeaway: Nkarta, Inc. announced its participation in two upcoming investor conferences, the Needham Virtual Healthcare Conference and the Canaccord Genuity Horizons in Oncology Virtual Conference. During these events, Nkarta will host a fireside chat and a panel discussion, respectively. The company is focused on transforming cancer treatment through its engineered natural killer (NK) cell therapies. Webcasts of the conferences will be available on Nkarta's website, promoting transparency and access to information for investors.
Market Sentiment Analysis
POSITIVE FACTORS
Nkarta is showcasing its innovative NK cell therapies at investor conferences.
Participation in key conferences could enhance investor interest and support.
The company's development of proprietary technology indicates potential future advancements in treatments.
Full Press Release Details
SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in two upcoming investor conferences:
Needham Virtual Healthcare Conference
1:30 p.m. ET – fireside chat
Canaccord Genuity Horizons in Oncology Virtual Conference
1:00 p.m. ET – panel discussion
A simultaneous webcast of each event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:
Frequently Asked Questions
What is Nkarta, Inc. known for?
Nkarta, Inc. develops engineered natural killer (NK) cell therapies.
What conferences is Nkarta participating in?
Nkarta will participate in the Needham Virtual Healthcare Conference and the Canaccord Genuity Horizons in Oncology Virtual Conference.
How can I access Nkarta's conference webcasts?
Webcasts will be available on Nkarta's Investors section of their website.
What technologies does Nkarta utilize?
Nkarta uses cell expansion, cryopreservation, and CRISPR-based genome engineering technologies.
Where can I find more information about Nkarta?
For more details, visit Nkarta's website at www.nkartatx.com.